JCN Newswire Read More Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting ruth 24 11 月 2 minutes TOKYO, Nov 24, 2022 – (J […]
JCN Newswire Read More Eisai to Present Latest Data on Perampanel and E2730 at the 75th American Epilepsy Society Annual Meeting ruth 30 11 月 2 minutes TOKYO, Nov 30, 2021 – (J […]
JCN Newswire Read More Eisai’s Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures ruth 2 8 月 3 minutes TOKYO, Aug 2, 2021 – (JC […]
JCN Newswire Read More Eisai: Discovery Research on AMPA-type Glutamate Receptor Antagonist Perampanel Honored With PSJ Award for Drug Research and Development 2021 ruth 26 3 月 5 minutes TOKYO, Mar 26, 2021 – (J […]
JCN Newswire Read More Eisai to Present Latest Data on Perampanel at the 74th American Epilepsy Society Annual Meeting ruth 30 11 月 3 minutes TOKYO, Nov 30, 2020 – (J […]
JCN Newswire Read More Eisai Receives Approval for Indication Expansion of Anti-Epileptic Agent Fycompa for Use in Pediatric Patients ruth 16 11 月 7 minutes TOKYO, Nov 16, 2020 – (J […]
JCN Newswire Read More Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures ruth 16 10 月 3 minutes TOKYO, Oct 16, 2020 – (J […]